Stock data

東洋 (4105)

東洋 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$911.42M, up 3.6% from a year earlier. EPS over the last four quarters totals NT$6.97.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 東洋 in Insightr